Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Pump.fun launches the "Spotlight" program to promote the listing of utility tokens on its platform

Pump.fun launches the "Spotlight" program to promote the listing of utility tokens on its platform

ForesightNewsForesightNews2025/11/01 05:23
Show original

Foresight News reported that Pump.fun has launched the "Spotlight" initiative to promote the listing of utility tokens, aiming to help utility tokens without meme attributes gain more attention and liquidity, thereby supporting the development of startups or projects and realizing its so-called "Internet Capital Market" era.


Pump.fun stated that the initiative will select teams whose tokens have utility value within the ecosystem and are integrated into the company's long-term strategy, and will assist these teams in formulating issuance plans. The Spotlight initiative is now open for applications, and relevant teams can fill in their information through the form link provided in the Spotlight X account's post.


It is currently unclear whether "Spotlight" will have a dedicated section on the Pump.fun platform, launch an independent site, or if it is simply the name of the initiative.


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.